Physician profile
Thomas C Bright
NPI 1811937378
$1,341.86
in general payments reported to CMS, 2019-2025
22 companies · $47.45 in 2025
The $47.45 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $183 · 2021: $105 · 2022: $409 · 2023: $55.83 · 2024: $78.40 · 2025: $47.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.11 | 2019-2023 | Lupron Depot |
| Boston Scientific Corporation | $156.89 | 2019-2025 | General - Erectile Dysfunction |
| Astellas Pharma US INC | $153.55 | 2019-2022 | |
| Allergan, INC. | $90.45 | 2019-2022 | |
| Janssen Biotech, INC. | $87.13 | 2019-2022 | |
| Urovant Sciences INC | $63.99 | 2021-2022 | |
| Coloplast Corp | $60.72 | 2021-2024 | Titan |
| Blue Earth Diagnostics | $57.00 | 2019-2022 | |
| Ambu INC. | $48.99 | 2022-2024 | |
| Myovant Sciences INC. | $37.72 | 2021-2022 | |
| Healthtronics Stone Solutions, LLC | $37.28 | 2019 | |
| Axonics, INC. | $35.98 | 2022-2023 | Axonics |
| Ethicon US, LLC | $27.94 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $25.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.66 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $22.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.21 | 2019 | |
| Antares Pharma, INC. | $20.79 | 2022 | |
| Neotract INC. | $20.38 | 2019 | |
| Cook Medical LLC | $17.14 | 2024 | Resonance |
| Travere Therapeutics, INC. | $13.34 | 2019 | |
| Dendreon Pharmaceuticals LLC | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.